Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 9.48

From 52W high−23.84%

Volume6.23M

Market capCNY 14.67B

P/E (TTM)42.0x

P/S (TTM)2.5x

Div yield1.55%

Key dataSep 18, 2026

Open

CNY 9.48

From 52W high

−23.84%

Volume

6.23M

Market cap

CNY 14.67B

ValuationView details →

P/E (Fwd)

32.2x

EV/EBITDA

19.4x

P/E (TTM)

42.0x

RSI (14)

38.9

MomentumView details →

1D Return

−4.49%

YTD Return

−20.70%

ValuationView details →

P/E (Fwd)

32.2x

P/E (TTM)

42.0x

EV/EBITDA

19.4x

EV/Sales

2.7x

P/S (TTM)

2.5x

P/B (TTM)

1.2x

ProfitabilityView details →

Gross Margin

33.54%

Net Margin

7.03%

EBITDA Margin

14.02%

ROE (TTM)

3.12%

ROA (TTM)

2.24%

Asset Turnover

0.32x

GrowthView details →

Revenue YoY

+2.15%

EPS YoY

−41.32%

FCF YoY

−13.73%

Revenue CAGR 3Y

−8.53%

EPS CAGR 3Y

−21.66%

EBITDA YoY

—

MomentumView details →

1D Return

−4.49%

YTD Return

−20.70%

1Y Return

−24.66%

RSI (14)

38.9

vs 50D SMA

−6.42%

vs 200D SMA

−13.52%

Capital & dividendView details →

Debt/Equity

0.23x

Current Ratio

2.15x

Quick Ratio

1.21x

Div Yield

1.55%

Div Rate

CNY 0.15

Div Growth 1Y

−42.00%

EarningsView details →

EPS (Actual)

CNY 0.06

EPS Surprise

−24.45%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.19

Avg Surprise (4Q)

−24.45%

Rev Surprise

−10.53%

Financials snapshotView financials →

Revenue (TTM)

5.24B

Net Income (TTM)

202.92M

Op. CF (TTM)

1.48B

Next earningsNov 4, 2026 →

Latest newsMore news →

Hepalink announced its H1 2026 results: revenue of 2.58 billion yuan, down 8.44% year-on-year; net profit attributable to shareholders of 275 million yuan, down 34.74% year-on-year; non-GAAP net profit of 162 million yuan, down 62.01% year-on-year. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.23d ago

Similar companies

中科三环000970.SZ 鸿富瀚301086.SZ 森麒麟002984.SZ 唯科科技301196.SZ 新兴铸管000778.SZ 海科新源301292.SZ Find similar companies →

Latest newsMore news →

Hepalink announced its H1 2026 results: revenue of 2.58 billion yuan, down 8.44% year-on-year; net profit attributable to shareholders of 275 million yuan, down 34.74% year-on-year; non-GAAP net profit of 162 million yuan, down 62.01% year-on-year. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.23d ago